ACLARION, INC. Long-Lived Assets
ACLARION, INC. (ACON) had Long-Lived Assets of $1.23 million as of 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Notes
us-gaap:NoncurrentAssets · last filed 2022-08-15
- 2022-06-30: Long-Lived Assets $1.23M.
- 2022-03-31: Long-Lived Assets $1.24M.
- 2021-12-31: Long-Lived Assets $1.16M.
| Period end | Long-Lived Assets |
|---|---|
| 2022-06-30 | $1.23M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $1.24M 10-Q · filed 2022-06-06 |
| 2021-12-31 | $1.16M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |